Pink Noise Boosts Brain Waste Clearance During Sleep

Throughout the day, hard-working brain cells accumulate metabolic waste products, including lactic acid and worn-out proteins. When people drift off into deep sleep at night, large waves of cerebrospinal fluid wash through the brain to flush away this cellular debris. Without this essential nighttime clean-up, lingering waste can trigger inflammation, disrupt communication between cells, and eventually contribute to neurodegenerative conditions.

Now, a team of researchers in a study published in Science Translational Medicine has shown that they can amplify these cleansing fluid waves by playing gentle, static-like sounds at precise moments during the sleep cycle. The work bridges sleep medicine and neurobiology, offering a glimpse into how brain activity can be manipulated to support neurological health.

How Pink Noise Triggers Deeper Brain Waves

The experimental approach relies on pink noise, a balanced acoustic signal similar to steady rain or a distant waterfall. Like white noise, it contains all frequencies audible to the human ear, but its lower pitches are louder while its higher pitches are softer. Researchers used 50-millisecond bursts of this sound, delivered at the peak of slow electrical waves that naturally occur during deep, non-REM sleep.

“Similar to a child on a swing, if you push them when they’re at the right moment in their movement, you can make that swing go farther. The challenge is: How do you find just the right time?”

Laura Lewis, Athinoula A. Martinos Associate Professor of Electrical Engineering and Computer Science at MIT

By timing the auditory stimuli to match the natural rhythm of the brain’s electrical slow waves, the research team increased the amplitude of those waves. In turn, these deepened electrical waves stimulated blood vessels to constrict and dilate, acting as a mechanical pump that drove significantly larger cerebrospinal fluid waves through the brain tissue during afternoon MRI scanning sessions involving 14 healthy volunteers.

Overcoming the Technical Hurdles of Simultaneous EEG and MRI

Executing the experiment required solving a formidable engineering challenge. To deliver the acoustic bursts precisely at the peak of a slow wave, investigators needed to monitor real-time EEG brain activity while participants slept inside an operating MRI scanner. Magnetic fields generated by MRI equipment notoriously interfere with EEG recordings, creating severe signal noise.

To bypass this hurdle, the team engineered a signal-processing method capable of eliminating fMRI-induced noise in under 100 milliseconds. Because a small lag time remained in the EEG measurement, the researchers also deployed a predictive algorithm that could accurately forecast when slow wave peaks would occur, allowing the pink noise bursts to land precisely on schedule.

From Laboratory Proof-of-Concept to Future Clinical Applications

While commercial sound machines and phone apps are popular for masking ambient noise, experts stress that playing continuous background noise at random will not replicate the laboratory findings. The cerebrospinal fluid response depended entirely on the exact phase of the slow-wave cycle in which the sound arrived.

To translate the technology beyond the laboratory, the study’s senior author Laura Lewis and lead author Joshua Levitt—who recently earned his PhD from Boston University—co-founded Cerebloom Inc., with a patent pending for a CSF-flow neurofeedback system. Levitt launched the company to develop a wearable headband that could eventually allow people to increase their brain waste clearance at home.

For now, sleep medicine specialists emphasize that the findings are a proof of concept conducted exclusively in healthy adults. Rebecca Robbins, an assistant professor of sleep medicine at Harvard Medical School and an associate scientist at Brigham and Women’s Hospital, noted that the study does not alter standard sleep hygiene advice. Meanwhile, the MIT team is preparing to investigate whether the technology can benefit older adults, individuals with insomnia, and patients with neurodegenerative conditions such as Alzheimer’s disease, where toxic protein aggregates like amyloid beta accumulate over time.